Discover how Quanticate supported an adaptive Phase 2 oncology study with integrated data management and statistical programming for PK/PD, safety, biomarker tracking, and dose decision-making in advanced prostate cancer.
See how Quanticate supported a decentralised Phase 3 clinical study with tailored data management, real-time oversight, and high-quality longitudinal data for regulatory use.
Discover how Quanticate supported adaptive dose-finding with clean data, consistent reporting, and timely decision support for a complex Phase 1 study.
Discover how Quanticate supported a complex early-phase study with expert clinical data management, biostatistics, and faster regulatory-ready data delivery.
A Case Study exploring the impact of safety Monitoring Committees and extended consultation support for a dose-finding Phase I Oncology Clinical Trial.
One of the most powerful aspects for ensuring a successful relationship, and a key part of the FSP model, is the governance between the sponsor and CRO
This case study presents a long-term Functional Service Provision with one of the top five pharmaceutical company across our biostatistics and clinical programming services.
Quanticate has been working successfully with a large Scandinavian pharmaceutical company over the past 12 months in the area of clinical data management (CDM) and is focused on the delivery of clean quality clinical trial databases.